A Combination of Systemic and Intracranial Anti-CD25 Immunotherapy Elicits a Long-Time Survival in Murine Model of Glioma
Figure 3
Combined anti-CD25 immunotherapy prolongs the survival of glioma-bearing mice. Kaplan-Meier survival graph showing a significant increase in the median length of survival in mice ( = 10) treated with systemic and intratumoral anti-CD25 mAb () and rechallenged with GL261.